nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—CYP3A4—bone cancer	0.72	1	CbGaD
Zopiclone—Eszopiclone—CYP3A4—bone cancer	0.00564	1	CrCbGaD
Zopiclone—CYP2E1—Felbamate Metabolism—CYP3A4—bone cancer	0.00308	0.0912	CbGpPWpGaD
Zopiclone—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00101	0.03	CbGpPWpGaD
Zopiclone—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000875	0.0259	CbGpPWpGaD
Zopiclone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000836	0.0248	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—FEV—bone cancer	0.000717	0.0212	CbGpPWpGaD
Zopiclone—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000712	0.0211	CbGpPWpGaD
Zopiclone—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000681	0.0202	CbGpPWpGaD
Zopiclone—GABRG3—Orphan transporters—TUBB4B—bone cancer	0.000612	0.0181	CbGpPWpGaD
Zopiclone—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000584	0.0173	CbGpPWpGaD
Zopiclone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000547	0.0162	CbGpPWpGaD
Zopiclone—GABRG3—Orphan transporters—TUBB2A—bone cancer	0.000528	0.0156	CbGpPWpGaD
Zopiclone—GABRB2—Orphan transporters—TUBB4B—bone cancer	0.000515	0.0153	CbGpPWpGaD
Zopiclone—GABRA5—Orphan transporters—TUBB4B—bone cancer	0.0005	0.0148	CbGpPWpGaD
Zopiclone—GABRA3—Orphan transporters—TUBB4B—bone cancer	0.000491	0.0145	CbGpPWpGaD
Zopiclone—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.000488	0.0145	CbGpPWpGaD
Zopiclone—GABRA2—Orphan transporters—TUBB4B—bone cancer	0.000483	0.0143	CbGpPWpGaD
Zopiclone—GABRB3—Orphan transporters—TUBB4B—bone cancer	0.00048	0.0142	CbGpPWpGaD
Zopiclone—GABRG2—Orphan transporters—TUBB4B—bone cancer	0.000471	0.0139	CbGpPWpGaD
Zopiclone—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.00047	0.0139	CbGpPWpGaD
Zopiclone—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00047	0.0139	CbGpPWpGaD
Zopiclone—Ataxia—Epirubicin—bone cancer	0.000464	0.00193	CcSEcCtD
Zopiclone—Tachycardia—Cisplatin—bone cancer	0.000461	0.00192	CcSEcCtD
Zopiclone—Dehydration—Epirubicin—bone cancer	0.000459	0.00191	CcSEcCtD
Zopiclone—Osteoarthritis—Doxorubicin—bone cancer	0.000456	0.0019	CcSEcCtD
Zopiclone—Diplopia—Doxorubicin—bone cancer	0.000456	0.0019	CcSEcCtD
Zopiclone—Hyperhidrosis—Cisplatin—bone cancer	0.000456	0.0019	CcSEcCtD
Zopiclone—Asthma—Methotrexate—bone cancer	0.000456	0.00189	CcSEcCtD
Zopiclone—Dry skin—Epirubicin—bone cancer	0.000452	0.00188	CcSEcCtD
Zopiclone—Anorexia—Cisplatin—bone cancer	0.00045	0.00187	CcSEcCtD
Zopiclone—Migraine—Doxorubicin—bone cancer	0.000449	0.00187	CcSEcCtD
Zopiclone—Affect lability—Doxorubicin—bone cancer	0.000449	0.00187	CcSEcCtD
Zopiclone—Hypokalaemia—Epirubicin—bone cancer	0.000449	0.00187	CcSEcCtD
Zopiclone—GABRB2—Orphan transporters—TUBB2A—bone cancer	0.000445	0.0132	CbGpPWpGaD
Zopiclone—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000444	0.00185	CcSEcCtD
Zopiclone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000442	0.0131	CbGpPWpGaD
Zopiclone—Face oedema—Doxorubicin—bone cancer	0.000441	0.00183	CcSEcCtD
Zopiclone—Gastritis—Epirubicin—bone cancer	0.000437	0.00182	CcSEcCtD
Zopiclone—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.000436	0.0129	CbGpPWpGaD
Zopiclone—Muscular weakness—Epirubicin—bone cancer	0.000435	0.00181	CcSEcCtD
Zopiclone—Mood swings—Doxorubicin—bone cancer	0.000432	0.0018	CcSEcCtD
Zopiclone—GABRA5—Orphan transporters—TUBB2A—bone cancer	0.000432	0.0128	CbGpPWpGaD
Zopiclone—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00043	0.00179	CcSEcCtD
Zopiclone—Ataxia—Doxorubicin—bone cancer	0.000429	0.00179	CcSEcCtD
Zopiclone—Asthma—Epirubicin—bone cancer	0.000426	0.00177	CcSEcCtD
Zopiclone—Influenza—Epirubicin—bone cancer	0.000426	0.00177	CcSEcCtD
Zopiclone—Dysphagia—Epirubicin—bone cancer	0.000426	0.00177	CcSEcCtD
Zopiclone—Dysuria—Methotrexate—bone cancer	0.000426	0.00177	CcSEcCtD
Zopiclone—Dehydration—Doxorubicin—bone cancer	0.000424	0.00177	CcSEcCtD
Zopiclone—GABRA3—Orphan transporters—TUBB2A—bone cancer	0.000424	0.0126	CbGpPWpGaD
Zopiclone—Paraesthesia—Cisplatin—bone cancer	0.000424	0.00176	CcSEcCtD
Zopiclone—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000422	0.0125	CbGpPWpGaD
Zopiclone—Dyspnoea—Cisplatin—bone cancer	0.000421	0.00175	CcSEcCtD
Zopiclone—Erectile dysfunction—Methotrexate—bone cancer	0.00042	0.00175	CcSEcCtD
Zopiclone—Dry skin—Doxorubicin—bone cancer	0.000418	0.00174	CcSEcCtD
Zopiclone—GABRA2—Orphan transporters—TUBB2A—bone cancer	0.000417	0.0123	CbGpPWpGaD
Zopiclone—Photosensitivity reaction—Methotrexate—bone cancer	0.000416	0.00173	CcSEcCtD
Zopiclone—Hypokalaemia—Doxorubicin—bone cancer	0.000415	0.00173	CcSEcCtD
Zopiclone—GABRB3—Orphan transporters—TUBB2A—bone cancer	0.000414	0.0123	CbGpPWpGaD
Zopiclone—GABRA1—Orphan transporters—TUBB4B—bone cancer	0.000412	0.0122	CbGpPWpGaD
Zopiclone—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000411	0.00171	CcSEcCtD
Zopiclone—Decreased appetite—Cisplatin—bone cancer	0.00041	0.00171	CcSEcCtD
Zopiclone—Bronchitis—Epirubicin—bone cancer	0.00041	0.00171	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Cisplatin—bone cancer	0.000408	0.0017	CcSEcCtD
Zopiclone—GABRG2—Orphan transporters—TUBB2A—bone cancer	0.000407	0.012	CbGpPWpGaD
Zopiclone—Drowsiness—Methotrexate—bone cancer	0.000406	0.00169	CcSEcCtD
Zopiclone—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000406	0.012	CbGpPWpGaD
Zopiclone—Depression—Methotrexate—bone cancer	0.000405	0.00168	CcSEcCtD
Zopiclone—Gastritis—Doxorubicin—bone cancer	0.000404	0.00168	CcSEcCtD
Zopiclone—Pain—Cisplatin—bone cancer	0.000404	0.00168	CcSEcCtD
Zopiclone—Muscular weakness—Doxorubicin—bone cancer	0.000403	0.00167	CcSEcCtD
Zopiclone—Dysuria—Epirubicin—bone cancer	0.000399	0.00166	CcSEcCtD
Zopiclone—Stomatitis—Methotrexate—bone cancer	0.000396	0.00165	CcSEcCtD
Zopiclone—Conjunctivitis—Methotrexate—bone cancer	0.000395	0.00164	CcSEcCtD
Zopiclone—Asthma—Doxorubicin—bone cancer	0.000394	0.00164	CcSEcCtD
Zopiclone—Influenza—Doxorubicin—bone cancer	0.000394	0.00164	CcSEcCtD
Zopiclone—Dysphagia—Doxorubicin—bone cancer	0.000394	0.00164	CcSEcCtD
Zopiclone—Pollakiuria—Epirubicin—bone cancer	0.000394	0.00164	CcSEcCtD
Zopiclone—Sweating—Methotrexate—bone cancer	0.000389	0.00162	CcSEcCtD
Zopiclone—Photosensitivity reaction—Epirubicin—bone cancer	0.000389	0.00162	CcSEcCtD
Zopiclone—Feeling abnormal—Cisplatin—bone cancer	0.000389	0.00162	CcSEcCtD
Zopiclone—Weight increased—Epirubicin—bone cancer	0.000388	0.00161	CcSEcCtD
Zopiclone—Haematuria—Methotrexate—bone cancer	0.000387	0.00161	CcSEcCtD
Zopiclone—Weight decreased—Epirubicin—bone cancer	0.000386	0.0016	CcSEcCtD
Zopiclone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—bone cancer	0.000385	0.0114	CbGpPWpGaD
Zopiclone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000385	0.0114	CbGpPWpGaD
Zopiclone—Epistaxis—Methotrexate—bone cancer	0.000383	0.00159	CcSEcCtD
Zopiclone—Drowsiness—Epirubicin—bone cancer	0.00038	0.00158	CcSEcCtD
Zopiclone—Bronchitis—Doxorubicin—bone cancer	0.000379	0.00158	CcSEcCtD
Zopiclone—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.000376	0.0111	CbGpPWpGaD
Zopiclone—Body temperature increased—Cisplatin—bone cancer	0.000373	0.00155	CcSEcCtD
Zopiclone—Neuropathy peripheral—Epirubicin—bone cancer	0.000373	0.00155	CcSEcCtD
Zopiclone—Stomatitis—Epirubicin—bone cancer	0.000371	0.00154	CcSEcCtD
Zopiclone—Urinary tract infection—Epirubicin—bone cancer	0.000369	0.00154	CcSEcCtD
Zopiclone—Conjunctivitis—Epirubicin—bone cancer	0.000369	0.00154	CcSEcCtD
Zopiclone—Dysuria—Doxorubicin—bone cancer	0.000369	0.00153	CcSEcCtD
Zopiclone—Hepatitis—Methotrexate—bone cancer	0.000365	0.00152	CcSEcCtD
Zopiclone—Sweating—Epirubicin—bone cancer	0.000364	0.00152	CcSEcCtD
Zopiclone—Pollakiuria—Doxorubicin—bone cancer	0.000364	0.00152	CcSEcCtD
Zopiclone—Haematuria—Epirubicin—bone cancer	0.000362	0.00151	CcSEcCtD
Zopiclone—Pharyngitis—Methotrexate—bone cancer	0.000362	0.00151	CcSEcCtD
Zopiclone—Photosensitivity reaction—Doxorubicin—bone cancer	0.00036	0.0015	CcSEcCtD
Zopiclone—Weight increased—Doxorubicin—bone cancer	0.000359	0.00149	CcSEcCtD
Zopiclone—Epistaxis—Epirubicin—bone cancer	0.000359	0.00149	CcSEcCtD
Zopiclone—Weight decreased—Doxorubicin—bone cancer	0.000357	0.00148	CcSEcCtD
Zopiclone—GABRA1—Orphan transporters—TUBB2A—bone cancer	0.000355	0.0105	CbGpPWpGaD
Zopiclone—Drowsiness—Doxorubicin—bone cancer	0.000352	0.00146	CcSEcCtD
Zopiclone—Hypersensitivity—Cisplatin—bone cancer	0.000348	0.00145	CcSEcCtD
Zopiclone—Erythema multiforme—Methotrexate—bone cancer	0.000345	0.00143	CcSEcCtD
Zopiclone—Neuropathy peripheral—Doxorubicin—bone cancer	0.000345	0.00143	CcSEcCtD
Zopiclone—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000344	0.0102	CbGpPWpGaD
Zopiclone—Stomatitis—Doxorubicin—bone cancer	0.000343	0.00143	CcSEcCtD
Zopiclone—Rhinitis—Epirubicin—bone cancer	0.000342	0.00142	CcSEcCtD
Zopiclone—Urinary tract infection—Doxorubicin—bone cancer	0.000342	0.00142	CcSEcCtD
Zopiclone—Conjunctivitis—Doxorubicin—bone cancer	0.000342	0.00142	CcSEcCtD
Zopiclone—Hepatitis—Epirubicin—bone cancer	0.000341	0.00142	CcSEcCtD
Zopiclone—Tinnitus—Methotrexate—bone cancer	0.00034	0.00141	CcSEcCtD
Zopiclone—Hypoaesthesia—Epirubicin—bone cancer	0.00034	0.00141	CcSEcCtD
Zopiclone—Asthenia—Cisplatin—bone cancer	0.000339	0.00141	CcSEcCtD
Zopiclone—Pharyngitis—Epirubicin—bone cancer	0.000339	0.00141	CcSEcCtD
Zopiclone—Sweating—Doxorubicin—bone cancer	0.000337	0.0014	CcSEcCtD
Zopiclone—Oedema peripheral—Epirubicin—bone cancer	0.000336	0.0014	CcSEcCtD
Zopiclone—Haematuria—Doxorubicin—bone cancer	0.000335	0.00139	CcSEcCtD
Zopiclone—Epistaxis—Doxorubicin—bone cancer	0.000332	0.00138	CcSEcCtD
Zopiclone—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.00033	0.00978	CbGpPWpGaD
Zopiclone—Chills—Methotrexate—bone cancer	0.000327	0.00136	CcSEcCtD
Zopiclone—Diarrhoea—Cisplatin—bone cancer	0.000323	0.00134	CcSEcCtD
Zopiclone—Erythema multiforme—Epirubicin—bone cancer	0.000323	0.00134	CcSEcCtD
Zopiclone—Alopecia—Methotrexate—bone cancer	0.000322	0.00134	CcSEcCtD
Zopiclone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000319	0.00946	CbGpPWpGaD
Zopiclone—Tinnitus—Epirubicin—bone cancer	0.000318	0.00132	CcSEcCtD
Zopiclone—Rhinitis—Doxorubicin—bone cancer	0.000317	0.00132	CcSEcCtD
Zopiclone—Hepatitis—Doxorubicin—bone cancer	0.000316	0.00131	CcSEcCtD
Zopiclone—Hypoaesthesia—Doxorubicin—bone cancer	0.000314	0.00131	CcSEcCtD
Zopiclone—Pharyngitis—Doxorubicin—bone cancer	0.000313	0.0013	CcSEcCtD
Zopiclone—Oedema peripheral—Doxorubicin—bone cancer	0.000311	0.00129	CcSEcCtD
Zopiclone—Dysgeusia—Methotrexate—bone cancer	0.000311	0.00129	CcSEcCtD
Zopiclone—Back pain—Methotrexate—bone cancer	0.000307	0.00128	CcSEcCtD
Zopiclone—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000306	0.00907	CbGpPWpGaD
Zopiclone—Chills—Epirubicin—bone cancer	0.000306	0.00127	CcSEcCtD
Zopiclone—PTGS1—Overview of nanoparticle effects—PTGS2—bone cancer	0.000302	0.00893	CbGpPWpGaD
Zopiclone—Alopecia—Epirubicin—bone cancer	0.000302	0.00125	CcSEcCtD
Zopiclone—Vomiting—Cisplatin—bone cancer	0.0003	0.00125	CcSEcCtD
Zopiclone—Vision blurred—Methotrexate—bone cancer	0.000299	0.00124	CcSEcCtD
Zopiclone—Erythema multiforme—Doxorubicin—bone cancer	0.000299	0.00124	CcSEcCtD
Zopiclone—Rash—Cisplatin—bone cancer	0.000298	0.00124	CcSEcCtD
Zopiclone—Dermatitis—Cisplatin—bone cancer	0.000297	0.00124	CcSEcCtD
Zopiclone—Ill-defined disorder—Methotrexate—bone cancer	0.000295	0.00123	CcSEcCtD
Zopiclone—Tinnitus—Doxorubicin—bone cancer	0.000294	0.00122	CcSEcCtD
Zopiclone—Anaemia—Methotrexate—bone cancer	0.000293	0.00122	CcSEcCtD
Zopiclone—Tension—Epirubicin—bone cancer	0.000292	0.00121	CcSEcCtD
Zopiclone—Dysgeusia—Epirubicin—bone cancer	0.000291	0.00121	CcSEcCtD
Zopiclone—Nervousness—Epirubicin—bone cancer	0.000289	0.0012	CcSEcCtD
Zopiclone—Back pain—Epirubicin—bone cancer	0.000287	0.0012	CcSEcCtD
Zopiclone—Malaise—Methotrexate—bone cancer	0.000286	0.00119	CcSEcCtD
Zopiclone—Muscle spasms—Epirubicin—bone cancer	0.000286	0.00119	CcSEcCtD
Zopiclone—Vertigo—Methotrexate—bone cancer	0.000285	0.00119	CcSEcCtD
Zopiclone—Chills—Doxorubicin—bone cancer	0.000283	0.00118	CcSEcCtD
Zopiclone—Nausea—Cisplatin—bone cancer	0.00028	0.00117	CcSEcCtD
Zopiclone—Vision blurred—Epirubicin—bone cancer	0.00028	0.00116	CcSEcCtD
Zopiclone—Alopecia—Doxorubicin—bone cancer	0.000279	0.00116	CcSEcCtD
Zopiclone—Ill-defined disorder—Epirubicin—bone cancer	0.000276	0.00115	CcSEcCtD
Zopiclone—Convulsion—Methotrexate—bone cancer	0.000275	0.00114	CcSEcCtD
Zopiclone—Anaemia—Epirubicin—bone cancer	0.000275	0.00114	CcSEcCtD
Zopiclone—Agitation—Epirubicin—bone cancer	0.000273	0.00114	CcSEcCtD
Zopiclone—Myalgia—Methotrexate—bone cancer	0.00027	0.00112	CcSEcCtD
Zopiclone—Chest pain—Methotrexate—bone cancer	0.00027	0.00112	CcSEcCtD
Zopiclone—Tension—Doxorubicin—bone cancer	0.00027	0.00112	CcSEcCtD
Zopiclone—Dysgeusia—Doxorubicin—bone cancer	0.000269	0.00112	CcSEcCtD
Zopiclone—Malaise—Epirubicin—bone cancer	0.000268	0.00111	CcSEcCtD
Zopiclone—Discomfort—Methotrexate—bone cancer	0.000267	0.00111	CcSEcCtD
Zopiclone—Nervousness—Doxorubicin—bone cancer	0.000267	0.00111	CcSEcCtD
Zopiclone—Vertigo—Epirubicin—bone cancer	0.000267	0.00111	CcSEcCtD
Zopiclone—Back pain—Doxorubicin—bone cancer	0.000266	0.00111	CcSEcCtD
Zopiclone—Muscle spasms—Doxorubicin—bone cancer	0.000264	0.0011	CcSEcCtD
Zopiclone—Palpitations—Epirubicin—bone cancer	0.000263	0.00109	CcSEcCtD
Zopiclone—Confusional state—Methotrexate—bone cancer	0.000261	0.00109	CcSEcCtD
Zopiclone—Anaphylactic shock—Methotrexate—bone cancer	0.000259	0.00108	CcSEcCtD
Zopiclone—Vision blurred—Doxorubicin—bone cancer	0.000259	0.00108	CcSEcCtD
Zopiclone—Convulsion—Epirubicin—bone cancer	0.000257	0.00107	CcSEcCtD
Zopiclone—Infection—Methotrexate—bone cancer	0.000257	0.00107	CcSEcCtD
Zopiclone—Hypertension—Epirubicin—bone cancer	0.000256	0.00107	CcSEcCtD
Zopiclone—Ill-defined disorder—Doxorubicin—bone cancer	0.000255	0.00106	CcSEcCtD
Zopiclone—Anaemia—Doxorubicin—bone cancer	0.000254	0.00106	CcSEcCtD
Zopiclone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000254	0.00751	CbGpPWpGaD
Zopiclone—Chest pain—Epirubicin—bone cancer	0.000253	0.00105	CcSEcCtD
Zopiclone—Myalgia—Epirubicin—bone cancer	0.000253	0.00105	CcSEcCtD
Zopiclone—Agitation—Doxorubicin—bone cancer	0.000253	0.00105	CcSEcCtD
Zopiclone—Anxiety—Epirubicin—bone cancer	0.000252	0.00105	CcSEcCtD
Zopiclone—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000251	0.00743	CbGpPWpGaD
Zopiclone—Hyperhidrosis—Methotrexate—bone cancer	0.00025	0.00104	CcSEcCtD
Zopiclone—PTGS1—Eicosanoid Synthesis—PTGS2—bone cancer	0.00025	0.00741	CbGpPWpGaD
Zopiclone—Discomfort—Epirubicin—bone cancer	0.00025	0.00104	CcSEcCtD
Zopiclone—Malaise—Doxorubicin—bone cancer	0.000248	0.00103	CcSEcCtD
Zopiclone—Dry mouth—Epirubicin—bone cancer	0.000247	0.00103	CcSEcCtD
Zopiclone—Vertigo—Doxorubicin—bone cancer	0.000247	0.00103	CcSEcCtD
Zopiclone—Anorexia—Methotrexate—bone cancer	0.000247	0.00103	CcSEcCtD
Zopiclone—Confusional state—Epirubicin—bone cancer	0.000244	0.00102	CcSEcCtD
Zopiclone—Palpitations—Doxorubicin—bone cancer	0.000243	0.00101	CcSEcCtD
Zopiclone—Anaphylactic shock—Epirubicin—bone cancer	0.000242	0.00101	CcSEcCtD
Zopiclone—Infection—Epirubicin—bone cancer	0.000241	0.001	CcSEcCtD
Zopiclone—Convulsion—Doxorubicin—bone cancer	0.000238	0.000991	CcSEcCtD
Zopiclone—Hypertension—Doxorubicin—bone cancer	0.000237	0.000987	CcSEcCtD
Zopiclone—Tachycardia—Epirubicin—bone cancer	0.000237	0.000984	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000236	0.000982	CcSEcCtD
Zopiclone—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000236	0.00699	CbGpPWpGaD
Zopiclone—Hyperhidrosis—Epirubicin—bone cancer	0.000234	0.000975	CcSEcCtD
Zopiclone—Insomnia—Methotrexate—bone cancer	0.000234	0.000975	CcSEcCtD
Zopiclone—Chest pain—Doxorubicin—bone cancer	0.000234	0.000973	CcSEcCtD
Zopiclone—Myalgia—Doxorubicin—bone cancer	0.000234	0.000973	CcSEcCtD
Zopiclone—Anxiety—Doxorubicin—bone cancer	0.000233	0.00097	CcSEcCtD
Zopiclone—Paraesthesia—Methotrexate—bone cancer	0.000233	0.000968	CcSEcCtD
Zopiclone—Discomfort—Doxorubicin—bone cancer	0.000231	0.000962	CcSEcCtD
Zopiclone—Anorexia—Epirubicin—bone cancer	0.000231	0.000961	CcSEcCtD
Zopiclone—Dyspnoea—Methotrexate—bone cancer	0.000231	0.000961	CcSEcCtD
Zopiclone—Somnolence—Methotrexate—bone cancer	0.00023	0.000958	CcSEcCtD
Zopiclone—Dry mouth—Doxorubicin—bone cancer	0.000229	0.000952	CcSEcCtD
Zopiclone—Dyspepsia—Methotrexate—bone cancer	0.000228	0.000949	CcSEcCtD
Zopiclone—Confusional state—Doxorubicin—bone cancer	0.000226	0.000941	CcSEcCtD
Zopiclone—Decreased appetite—Methotrexate—bone cancer	0.000225	0.000937	CcSEcCtD
Zopiclone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000225	0.00665	CbGpPWpGaD
Zopiclone—Anaphylactic shock—Doxorubicin—bone cancer	0.000224	0.000933	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Methotrexate—bone cancer	0.000224	0.00093	CcSEcCtD
Zopiclone—Fatigue—Methotrexate—bone cancer	0.000223	0.000929	CcSEcCtD
Zopiclone—Infection—Doxorubicin—bone cancer	0.000223	0.000927	CcSEcCtD
Zopiclone—GABRB3—BDNF signaling pathway—EIF2S1—bone cancer	0.000223	0.00659	CbGpPWpGaD
Zopiclone—Pain—Methotrexate—bone cancer	0.000222	0.000921	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000221	0.000919	CcSEcCtD
Zopiclone—PTGS1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00022	0.00651	CbGpPWpGaD
Zopiclone—Insomnia—Epirubicin—bone cancer	0.000219	0.000912	CcSEcCtD
Zopiclone—Tachycardia—Doxorubicin—bone cancer	0.000219	0.000911	CcSEcCtD
Zopiclone—Paraesthesia—Epirubicin—bone cancer	0.000218	0.000906	CcSEcCtD
Zopiclone—Hyperhidrosis—Doxorubicin—bone cancer	0.000217	0.000902	CcSEcCtD
Zopiclone—Dyspnoea—Epirubicin—bone cancer	0.000216	0.000899	CcSEcCtD
Zopiclone—Somnolence—Epirubicin—bone cancer	0.000216	0.000896	CcSEcCtD
Zopiclone—Anorexia—Doxorubicin—bone cancer	0.000214	0.000889	CcSEcCtD
Zopiclone—Feeling abnormal—Methotrexate—bone cancer	0.000213	0.000888	CcSEcCtD
Zopiclone—Dyspepsia—Epirubicin—bone cancer	0.000213	0.000888	CcSEcCtD
Zopiclone—Gastrointestinal pain—Methotrexate—bone cancer	0.000212	0.000881	CcSEcCtD
Zopiclone—Decreased appetite—Epirubicin—bone cancer	0.000211	0.000877	CcSEcCtD
Zopiclone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.000209	0.0062	CbGpPWpGaD
Zopiclone—Gastrointestinal disorder—Epirubicin—bone cancer	0.000209	0.000871	CcSEcCtD
Zopiclone—Fatigue—Epirubicin—bone cancer	0.000209	0.000869	CcSEcCtD
Zopiclone—Constipation—Epirubicin—bone cancer	0.000207	0.000862	CcSEcCtD
Zopiclone—Pain—Epirubicin—bone cancer	0.000207	0.000862	CcSEcCtD
Zopiclone—Urticaria—Methotrexate—bone cancer	0.000206	0.000856	CcSEcCtD
Zopiclone—Abdominal pain—Methotrexate—bone cancer	0.000205	0.000852	CcSEcCtD
Zopiclone—Body temperature increased—Methotrexate—bone cancer	0.000205	0.000852	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000204	0.00085	CcSEcCtD
Zopiclone—Insomnia—Doxorubicin—bone cancer	0.000203	0.000844	CcSEcCtD
Zopiclone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000203	0.00601	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000202	0.00598	CbGpPWpGaD
Zopiclone—Paraesthesia—Doxorubicin—bone cancer	0.000201	0.000838	CcSEcCtD
Zopiclone—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.0002	0.00593	CbGpPWpGaD
Zopiclone—Dyspnoea—Doxorubicin—bone cancer	0.0002	0.000832	CcSEcCtD
Zopiclone—Feeling abnormal—Epirubicin—bone cancer	0.0002	0.000831	CcSEcCtD
Zopiclone—Somnolence—Doxorubicin—bone cancer	0.000199	0.00083	CcSEcCtD
Zopiclone—Gastrointestinal pain—Epirubicin—bone cancer	0.000198	0.000825	CcSEcCtD
Zopiclone—Dyspepsia—Doxorubicin—bone cancer	0.000197	0.000821	CcSEcCtD
Zopiclone—Decreased appetite—Doxorubicin—bone cancer	0.000195	0.000811	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000194	0.000806	CcSEcCtD
Zopiclone—Fatigue—Doxorubicin—bone cancer	0.000193	0.000804	CcSEcCtD
Zopiclone—Urticaria—Epirubicin—bone cancer	0.000193	0.000801	CcSEcCtD
Zopiclone—Constipation—Doxorubicin—bone cancer	0.000192	0.000798	CcSEcCtD
Zopiclone—Pain—Doxorubicin—bone cancer	0.000192	0.000798	CcSEcCtD
Zopiclone—Abdominal pain—Epirubicin—bone cancer	0.000192	0.000797	CcSEcCtD
Zopiclone—Body temperature increased—Epirubicin—bone cancer	0.000192	0.000797	CcSEcCtD
Zopiclone—Hypersensitivity—Methotrexate—bone cancer	0.000191	0.000794	CcSEcCtD
Zopiclone—Asthenia—Methotrexate—bone cancer	0.000186	0.000773	CcSEcCtD
Zopiclone—Feeling abnormal—Doxorubicin—bone cancer	0.000185	0.000769	CcSEcCtD
Zopiclone—Gastrointestinal pain—Doxorubicin—bone cancer	0.000183	0.000763	CcSEcCtD
Zopiclone—Pruritus—Methotrexate—bone cancer	0.000183	0.000762	CcSEcCtD
Zopiclone—Hypersensitivity—Epirubicin—bone cancer	0.000179	0.000743	CcSEcCtD
Zopiclone—Urticaria—Doxorubicin—bone cancer	0.000178	0.000741	CcSEcCtD
Zopiclone—Abdominal pain—Doxorubicin—bone cancer	0.000177	0.000738	CcSEcCtD
Zopiclone—Body temperature increased—Doxorubicin—bone cancer	0.000177	0.000738	CcSEcCtD
Zopiclone—Diarrhoea—Methotrexate—bone cancer	0.000177	0.000737	CcSEcCtD
Zopiclone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000175	0.00519	CbGpPWpGaD
Zopiclone—Asthenia—Epirubicin—bone cancer	0.000174	0.000724	CcSEcCtD
Zopiclone—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000173	0.00512	CbGpPWpGaD
Zopiclone—Pruritus—Epirubicin—bone cancer	0.000172	0.000713	CcSEcCtD
Zopiclone—Dizziness—Methotrexate—bone cancer	0.000171	0.000713	CcSEcCtD
Zopiclone—Diarrhoea—Epirubicin—bone cancer	0.000166	0.00069	CcSEcCtD
Zopiclone—Hypersensitivity—Doxorubicin—bone cancer	0.000165	0.000687	CcSEcCtD
Zopiclone—Vomiting—Methotrexate—bone cancer	0.000165	0.000685	CcSEcCtD
Zopiclone—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000164	0.00487	CbGpPWpGaD
Zopiclone—Rash—Methotrexate—bone cancer	0.000163	0.000679	CcSEcCtD
Zopiclone—Dermatitis—Methotrexate—bone cancer	0.000163	0.000679	CcSEcCtD
Zopiclone—Headache—Methotrexate—bone cancer	0.000162	0.000675	CcSEcCtD
Zopiclone—Asthenia—Doxorubicin—bone cancer	0.000161	0.000669	CcSEcCtD
Zopiclone—Dizziness—Epirubicin—bone cancer	0.00016	0.000667	CcSEcCtD
Zopiclone—Pruritus—Doxorubicin—bone cancer	0.000159	0.00066	CcSEcCtD
Zopiclone—Vomiting—Epirubicin—bone cancer	0.000154	0.000641	CcSEcCtD
Zopiclone—Nausea—Methotrexate—bone cancer	0.000154	0.00064	CcSEcCtD
Zopiclone—Diarrhoea—Doxorubicin—bone cancer	0.000153	0.000638	CcSEcCtD
Zopiclone—Rash—Epirubicin—bone cancer	0.000153	0.000636	CcSEcCtD
Zopiclone—Dermatitis—Epirubicin—bone cancer	0.000153	0.000635	CcSEcCtD
Zopiclone—Headache—Epirubicin—bone cancer	0.000152	0.000632	CcSEcCtD
Zopiclone—GABRG3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000149	0.00442	CbGpPWpGaD
Zopiclone—Dizziness—Doxorubicin—bone cancer	0.000148	0.000617	CcSEcCtD
Zopiclone—Nausea—Epirubicin—bone cancer	0.000144	0.000599	CcSEcCtD
Zopiclone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000143	0.00422	CbGpPWpGaD
Zopiclone—Vomiting—Doxorubicin—bone cancer	0.000143	0.000593	CcSEcCtD
Zopiclone—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000142	0.00421	CbGpPWpGaD
Zopiclone—Rash—Doxorubicin—bone cancer	0.000141	0.000588	CcSEcCtD
Zopiclone—Dermatitis—Doxorubicin—bone cancer	0.000141	0.000588	CcSEcCtD
Zopiclone—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000141	0.00417	CbGpPWpGaD
Zopiclone—Headache—Doxorubicin—bone cancer	0.000141	0.000585	CcSEcCtD
Zopiclone—PTGS1—Arachidonic acid metabolism—PTGS2—bone cancer	0.000139	0.00412	CbGpPWpGaD
Zopiclone—Nausea—Doxorubicin—bone cancer	0.000133	0.000554	CcSEcCtD
Zopiclone—GABRG3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000129	0.00382	CbGpPWpGaD
Zopiclone—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000126	0.00373	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000126	0.00372	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000122	0.00362	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00012	0.00355	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000118	0.00349	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000117	0.00347	CbGpPWpGaD
Zopiclone—PTGS1—Biological oxidations—CYP3A4—bone cancer	0.000117	0.00346	CbGpPWpGaD
Zopiclone—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000116	0.00342	CbGpPWpGaD
Zopiclone—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000115	0.00341	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000115	0.00341	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000109	0.00321	CbGpPWpGaD
Zopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000106	0.00314	CbGpPWpGaD
Zopiclone—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000106	0.00313	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000105	0.00312	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000104	0.00307	CbGpPWpGaD
Zopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000103	0.00305	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000102	0.00301	CbGpPWpGaD
Zopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000101	0.003	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000101	0.00299	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000101	0.00298	CbGpPWpGaD
Zopiclone—PTGS1—Biological oxidations—GSTP1—bone cancer	9.99e-05	0.00296	CbGpPWpGaD
Zopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	9.94e-05	0.00294	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.93e-05	0.00294	CbGpPWpGaD
Zopiclone—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	9.88e-05	0.00293	CbGpPWpGaD
Zopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	9.7e-05	0.00287	CbGpPWpGaD
Zopiclone—GABRG3—Transmission across Chemical Synapses—BRAF—bone cancer	9.47e-05	0.00281	CbGpPWpGaD
Zopiclone—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	8.99e-05	0.00266	CbGpPWpGaD
Zopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	8.89e-05	0.00263	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—PTGS2—bone cancer	8.85e-05	0.00262	CbGpPWpGaD
Zopiclone—CYP2E1—Biological oxidations—CYP3A4—bone cancer	8.73e-05	0.00259	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.68e-05	0.00257	CbGpPWpGaD
Zopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	8.63e-05	0.00256	CbGpPWpGaD
Zopiclone—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	8.61e-05	0.00255	CbGpPWpGaD
Zopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	8.48e-05	0.00251	CbGpPWpGaD
Zopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	8.48e-05	0.00251	CbGpPWpGaD
Zopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	8.33e-05	0.00247	CbGpPWpGaD
Zopiclone—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	8.28e-05	0.00245	CbGpPWpGaD
Zopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	8.13e-05	0.00241	CbGpPWpGaD
Zopiclone—GABRB2—Transmission across Chemical Synapses—BRAF—bone cancer	7.97e-05	0.00236	CbGpPWpGaD
Zopiclone—GABRG3—Transmission across Chemical Synapses—MDM2—bone cancer	7.94e-05	0.00235	CbGpPWpGaD
Zopiclone—GABRA5—Transmission across Chemical Synapses—BRAF—bone cancer	7.75e-05	0.00229	CbGpPWpGaD
Zopiclone—GABRA3—Transmission across Chemical Synapses—BRAF—bone cancer	7.61e-05	0.00225	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—CYP3A4—bone cancer	7.55e-05	0.00224	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—BRAF—bone cancer	7.48e-05	0.00221	CbGpPWpGaD
Zopiclone—CYP2E1—Biological oxidations—GSTP1—bone cancer	7.47e-05	0.00221	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	7.44e-05	0.0022	CbGpPWpGaD
Zopiclone—GABRB3—Transmission across Chemical Synapses—BRAF—bone cancer	7.43e-05	0.0022	CbGpPWpGaD
Zopiclone—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	7.37e-05	0.00218	CbGpPWpGaD
Zopiclone—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	7.31e-05	0.00217	CbGpPWpGaD
Zopiclone—GABRG2—Transmission across Chemical Synapses—BRAF—bone cancer	7.29e-05	0.00216	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—BRAF—bone cancer	7.26e-05	0.00215	CbGpPWpGaD
Zopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	7.1e-05	0.0021	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—JUN—bone cancer	7.03e-05	0.00208	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—NDUFA12—bone cancer	7e-05	0.00207	CbGpPWpGaD
Zopiclone—GABRB2—Transmission across Chemical Synapses—MDM2—bone cancer	6.68e-05	0.00198	CbGpPWpGaD
Zopiclone—GABRA5—Transmission across Chemical Synapses—MDM2—bone cancer	6.49e-05	0.00192	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—GSTP1—bone cancer	6.46e-05	0.00191	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—BRAF—bone cancer	6.37e-05	0.00189	CbGpPWpGaD
Zopiclone—GABRA3—Transmission across Chemical Synapses—MDM2—bone cancer	6.37e-05	0.00189	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	6.37e-05	0.00189	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—MDM2—bone cancer	6.26e-05	0.00185	CbGpPWpGaD
Zopiclone—GABRB3—Transmission across Chemical Synapses—MDM2—bone cancer	6.22e-05	0.00184	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—CYP3A4—bone cancer	6.14e-05	0.00182	CbGpPWpGaD
Zopiclone—GABRG2—Transmission across Chemical Synapses—MDM2—bone cancer	6.11e-05	0.00181	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—BRAF—bone cancer	6.11e-05	0.00181	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—MDM2—bone cancer	6.08e-05	0.0018	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	6.06e-05	0.00179	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—BRAF—bone cancer	5.94e-05	0.00176	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—BRAF—bone cancer	5.83e-05	0.00173	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—NT5C3A—bone cancer	5.8e-05	0.00172	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—BRAF—bone cancer	5.73e-05	0.0017	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—BRAF—bone cancer	5.69e-05	0.00169	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—JUN—bone cancer	5.66e-05	0.00168	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—BRAF—bone cancer	5.59e-05	0.00165	CbGpPWpGaD
Zopiclone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	5.35e-05	0.00158	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—MDM2—bone cancer	5.34e-05	0.00158	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—GSTP1—bone cancer	5.25e-05	0.00156	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NDUFA12—bone cancer	5.23e-05	0.00155	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	5.18e-05	0.00153	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—MDM2—bone cancer	5.12e-05	0.00152	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—MDM2—bone cancer	4.97e-05	0.00147	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—BRAF—bone cancer	4.88e-05	0.00145	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—MDM2—bone cancer	4.88e-05	0.00145	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—MDM2—bone cancer	4.8e-05	0.00142	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—MDM2—bone cancer	4.77e-05	0.00141	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—MDM2—bone cancer	4.68e-05	0.00139	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NDUFA12—bone cancer	4.52e-05	0.00134	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NT5C3A—bone cancer	4.34e-05	0.00128	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—MDM2—bone cancer	4.09e-05	0.00121	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NT5C3A—bone cancer	3.75e-05	0.00111	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NDUFA12—bone cancer	3.68e-05	0.00109	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.47e-05	0.00103	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.42e-05	0.00101	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NT5C3A—bone cancer	3.05e-05	0.000904	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ENO2—bone cancer	2.54e-05	0.000753	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NDUFA12—bone cancer	2.43e-05	0.000719	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—DHFR—bone cancer	2.36e-05	0.000698	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GNA11—bone cancer	2.2e-05	0.000653	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NT5C3A—bone cancer	2.01e-05	0.000596	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP3A4—bone cancer	2e-05	0.000592	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.99e-05	0.000589	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ENO2—bone cancer	1.9e-05	0.000563	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—DHFR—bone cancer	1.76e-05	0.000522	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTP1—bone cancer	1.71e-05	0.000506	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GNA11—bone cancer	1.65e-05	0.000488	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ENO2—bone cancer	1.64e-05	0.000486	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—DHFR—bone cancer	1.52e-05	0.000451	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP3A4—bone cancer	1.49e-05	0.000442	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GNA11—bone cancer	1.42e-05	0.000422	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ENO2—bone cancer	1.34e-05	0.000396	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP3A4—bone cancer	1.29e-05	0.000382	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.28e-05	0.00038	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTP1—bone cancer	1.28e-05	0.000378	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—DHFR—bone cancer	1.24e-05	0.000367	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GNA11—bone cancer	1.16e-05	0.000343	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTP1—bone cancer	1.1e-05	0.000327	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP3A4—bone cancer	1.05e-05	0.000311	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.05e-05	0.00031	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTP1—bone cancer	8.99e-06	0.000266	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PTGS2—bone cancer	8.85e-06	0.000262	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ENO2—bone cancer	8.81e-06	0.000261	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—DHFR—bone cancer	8.18e-06	0.000242	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GNA11—bone cancer	7.64e-06	0.000226	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PTGS2—bone cancer	6.62e-06	0.000196	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTP1—bone cancer	5.93e-06	0.000175	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PTGS2—bone cancer	5.72e-06	0.000169	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PTGS2—bone cancer	4.66e-06	0.000138	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PTGS2—bone cancer	3.07e-06	9.09e-05	CbGpPWpGaD
